Hundreds of Women Reporting Negative Side-Effects of Essure Reports The Bell Law Firm
Hundreds of women are coming forward to discuss their experiences with Essure.
More than 700,000 women have undergone the procedure to get the permanent birth control system inserted into their fallopian tubes and over 800 have reported adverse events to the Food and Drug Administration (FDA).
Approved in 2004, Essure is a permanent birth control system that works by creating scar tissue that will block the fallopian tubes after the device is inserted. During clinical trials involving 745 women more than 3 percent of women experienced some type of adverse event.
Some common side-effects women are reporting to the FDA include:
• Excessive Bleeding
• Unexpected Pregnancy
• Coil Migration & Embedment
• Fallopian Tube Perforation
Many patients who experienced such side-effects had to undergo hysterectomies in order to remove the device, a procedure many were avoiding.
When the FDA approved the device it was given preemptive status which means the manufacturer cannot be sued. However, many women are trying to get the device removed from the market so that no one else will have to suffer through such an ordeal.
If you or a loved one has suffered injuries due to a defective medical device, the victim may be entitled to compensation for medical expenses, pain and suffering, lost wages, and more.
For more information, visit www.belllaw.com.
About The Bell Law Firm
The Bell Law Firm is committed to helping all those who have been injured by the actions or negligence of another person or entity. The personal injury law firm based in Charleston, West Virginia handles all types of personal injury claims including auto accidents, medical malpractice, product defects, defective drugs, work injuries, mesothelioma, and nursing home negligence.
The Bell Law Firm
30 Capitol Street
Charleston, WV 25301
The Bell Law Firm
PMP Marketing Group
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.